- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Rivaroxaban (Xarelto, BAY59-7939)
Total 246 results
-
BayerJanssen Research & Development, LLCCompletedCoronary Artery Disease | Cardiovascular DiseaseBelgium, Netherlands
-
BayerJanssen Research & Development, LLCCompletedVenous ThrombosisFrance, United States, Switzerland, Netherlands, Canada, Germany, Austria, Australia, Israel, Italy
-
BayerJanssen Research & Development, LLCCompleted
-
BayerCompletedTreatment of Venous ThromboembolismJapan
-
BayerJanssen Research & Development, LLCCompletedVenous ThromboembolismJapan
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationColombia, Kazakhstan, Mexico, Russian Federation, Argentina, Azerbaijan, Bahrain, Chile, Egypt, Georgia, Jordan, Kenya, Lebanon, Saudi Arabia, United Arab Emirates, Uruguay, Venezuela
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipRussian Federation
-
BayerJanssen Scientific Affairs, LLCCompleted
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationFrance, Germany, Turkey, Russian Federation, Bulgaria, Ukraine, Poland
-
BayerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedTherapeutic EquivalencyGermany
-
BayerJanssen Research & Development, LLCCompletedNon-valvular Atrial FibrillationItaly
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationAustria, Czechia, Hungary, Israel, Russian Federation, Slovakia, Slovenia, Germany, United Kingdom, France, Belgium, Canada, Netherlands, Poland, Denmark, Sweden, Portugal, Ireland, Norway, Moldova, Republic of, Ukraine
-
BayerJanssen Research & Development, LLC; RTI Health SolutionsCompletedAnticoagulationGermany, United Kingdom, France, Spain
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompletedThrombosisCanada, United States, Belgium, Spain, Italy, France, Finland, Hungary
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompletedVenous ThromboembolismSwitzerland, Spain, United States, Austria, Italy, Russian Federation, United Kingdom, Brazil, Australia, Canada, Hungary, Netherlands, Israel, Poland, Japan
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationIndonesia, Korea, Republic of, Malaysia, Singapore, Thailand, Philippines, Taiwan, Hong Kong, India, Pakistan, Vietnam
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Scientific Affairs, LLCCompleted
-
BayerJanssen Research & Development, LLCCompletedVenous Thrombosis | PediatricsItaly, United States, Austria, Australia, Canada, France, Switzerland, Germany, Israel, Ireland
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompletedThromboembolismSpain, Austria, Israel, Italy, France, Turkey, Germany
-
BayerJanssen Research & Development, LLCNot yet recruitingChildren | Congenital Heart Disease | Prevention of Venous Thromboembolism | Fontan ProcedureJapan
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompleted
-
BayerJanssen Research & Development, LLCCompletedAtrial FibrillationKorea, Republic of, Taiwan
-
BayerJanssen Research & Development, LLCCompletedVenous ThrombosisFrance
-
BayerJanssen Scientific Affairs, LLCCompleted
-
BayerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedVenous Thrombosis | Deep Vein ThrombosisItaly, Austria, Brazil, Hungary, Netherlands, South Africa, Israel, Australia, Germany
-
BayerCompletedNon-valvular Atrial Fibrillation (NVAF)Korea, Republic of
-
BayerJohnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedVenous ThromboembolismUnited Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, New Zealand, Poland, India, United States, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Taiwan, Brazil, Denmark, German... and more
-
BayerJanssen R&D, L.L.C.Completed
-
BayerJanssen Research & Development, LLCCompletedCancer | Venous Thromboembolism | Treatment of Venous Thromboembolism in Cancer PatientsGermany
-
BayerWithdrawnTotal Hip Replacement | Total Knee Replacement | Prophylaxis, Thromboembolism, Venous
-
Janssen Research & Development, LLCBayerCompletedHeart Failure | Rheumatic Diseases | Respiratory Insufficiency | Infectious Diseases | Stroke AcuteUnited States, Poland, Ukraine, United Kingdom, Germany, Spain, Argentina, Belarus, Colombia, Israel, Mexico, Portugal, Bulgaria, Romania, Serbia, South Africa, Turkey, Canada, Australia, Netherlands, Denmark, Greece, Peru, Brazil, Russian... and more
-
BayerJanssen Scientific Affairs, LLCCompleted
-
BayerJanssen Research & Development, LLCCompleted
-
BayerCompletedVenous ThromboembolismUnited States, Canada
-
BayerJanssen Pharmaceutical Companies (formerly Johnson & Johnson Pharmaceutical...Recruiting
-
BayerJanssen Scientific Affairs, LLCCompletedNon-valvular Atrial Fibrillation (NVAF)Japan
-
BayerJanssen Research & Development, LLCCompletedTreatment of Venous Thromboembolism in Cancer PatientsUnited Kingdom
-
BayerJanssen Research & Development, LLCCompletedBiological AvailabilityGermany
-
BayerJanssen Research & Development, LLCCompletedVenous Thrombosis | Deep Vein ThrombosisSwitzerland, France, Germany, Hungary, Spain, Sweden, Austria, Czech Republic, Italy, Moldova, Republic of, Slovenia, Ukraine, United Kingdom, Israel, Portugal, Belgium, Denmark, Greece, Netherlands, Canada, Norway
-
BayerCompletedVenous ThromboembolismItaly, Spain, Denmark, Netherlands, Belgium, Austria, Germany, Poland, Sweden, Israel, Norway, United Kingdom, France
-
BayerJanssen Research & Development, LLCCompleted